Gastroenterology
Volume 138, Issue 5 , Pages 1704-1713 , May 2010

Selenium Status and the Risk of Esophageal and Gastric Cancer Subtypes: The Netherlands Cohort Study

  • Jessie Steevens

      Affiliations

    • GROW-School for Oncology and Developmental Biology, Department of Epidemiology, Maastricht University Medical Centre+, Maastricht, The Netherlands
    • Corresponding Author InformationReprint requests Address requests for reprints to: Jessie Steevens, MSc, GROW-School for Oncology and Developmental Biology, Department of Epidemiology, Maastricht University Medical Centre+, PO Box 616, 6200 MD Maastricht, The Netherlands. fax (31) 043 3884128
    • ,
  • Piet A. van den Brandt

      Affiliations

    • GROW-School for Oncology and Developmental Biology, Department of Epidemiology, Maastricht University Medical Centre+, Maastricht, The Netherlands
    • ,
  • R. Alexandra Goldbohm

      Affiliations

    • Department of Prevention and Health, TNO Quality of Life, Leiden, The Netherlands
    • ,
  • Leo J. Schouten

      Affiliations

    • GROW-School for Oncology and Developmental Biology, Department of Epidemiology, Maastricht University Medical Centre+, Maastricht, The Netherlands

Received 20 August 2009 ,Accepted 3 December 2009.

References 

  1. Navarro Silvera SA, Rohan TE. Trace elements and cancer risk: a review of the epidemiologic evidence. Cancer Causes Control. 2007;18:7–27
  2. Jackson MI, Combs GF. Selenium and anticarcinogenesis: underlying mechanisms. Curr Opin Clin Nutr Metab Care. 2008;11:718–726
  3. Rayman MP. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc. 2005;64:527–542
  4. Navarro-Alarcon M, Cabrera-Vique C. Selenium in food and the human body: a review. Sci Total Environ. 2008;400:115–141
  5. Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: Institute of Medicine; 2000;
  6. Netherlands Nutrition Centre. http://www.voedingscentrum.nl/nl/eten-gezondheid/voedingstoffen/vitamines-en-mineralen/hoeveel-heb-je-nodig.aspx#cAccessed August 13, 2009
  7. Hulshof KFAM, Kistemaker C, Kruizinga AG. The contribution of food groups to the intake of energy and nutrients. Dutch National Food Consumption Survey 1997–1998. Zeist: TNO; 1998;
  8. van ‘t Veer P, van der Wielen RP, Kok FJ, et al. Selenium in diet, blood, and toenails in relation to breast cancer: a case-control study. Am J Epidemiol. 1990;131:987–994
  9. Willett WC, Buzzard IM. Foods and nutrients. In:  Willett WC editors. Monographs in epidemiology and biostatistics. Volume 30. Nutritional epidemiology. New York: Oxford Universtiy Press; 1998;p. 18–32
  10. Hunter DJ, Morris JS, Chute CG, et al. Predictors of selenium concentration in human toenails. Am J Epidemiol. 1990;132:114–122
  11. Longnecker MP, Stram DO, Taylor PR, et al. Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiology. 1996;7:384–390
  12. Ujiie S, Kikuchi H. The relation between serum selenium value and cancer in Miyagi, Japan: 5-year follow up study. Tohoku J Exp Med. 2002;196:99–109
  13. Jaskiewicz K, Marasas WF, Rossouw JE, et al. Selenium and other mineral elements in populations at risk for esophageal cancer. Cancer. 1988;62:2635–2639
  14. Knekt P, Aromaa A, Maatela J, et al. Serum micronutrients and risk of cancers of low incidence in Finland. Am J Epidemiol. 1991;134:356–361
  15. Clark LC, Combs GF, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin (A randomized controlled trial. Nutritional Prevention of Cancer Study Group). JAMA. 1996;276:1957–1963
  16. Krishnaswamy K, Prasad MP, Krishna TP, et al. A case control study of selenium in cancer. Indian J Med Res. 1993;98:124–128
  17. Mark SD, Qiao YL, Dawsey SM, et al. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst. 2000;92:1753–1763
  18. Wei WQ, Abnet CC, Qiao YL, et al. Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr. 2004;79:80–85
  19. Limburg PJ, Wei W, Ahnen DJ, et al. Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib. Gastroenterology. 2005;129:863–873
  20. Lu H, Cai L, Mu LN, et al. Dietary mineral and trace element intake and squamous cell carcinoma of the esophagus in a Chinese population. Nutr Cancer. 2006;55:63–70
  21. Rudolph RE, Vaughan TL, Kristal AR, et al. Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus. J Natl Cancer Inst. 2003;95:750–757
  22. Liu C, Russell RM. Nutrition and gastric cancer risk: an update. Nutr Rev. 2008;66:237–249
  23. van den Brandt PA, Goldbohm RA, van ‘t Veer P, et al. A prospective cohort study on toenail selenium levels and risk of gastrointestinal cancer. J Natl Cancer Inst. 1993;85:224–229
  24. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst. 1993;85:1483–1492
  25. Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol. 2006;17:2–9
  26. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol. 2003;56:1–9
  27. Vizcaino AP, Moreno V, Lambert R, et al. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995. Int J Cancer. 2002;99:860–868
  28. Steevens J, Botterweck AA, Dirx MJ, et al. Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol. 2010;(In press)
  29. Mena S, Ortega A, Estrela JM. Oxidative stress in environmental-induced carcinogenesis. Mutat Res. 2009;674:36–44
  30. Knekt P, Aromaa A, Maatela J, et al. Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst. 1990;82:864–868
  31. van den Brandt PA, Zeegers MP, Bode P, et al. Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2003;12:866–871
  32. van den Brandt PA, Goldbohm RA, van ‘t Veer P, et al. A large-scale prospective cohort study on diet and cancer in The Netherlands. J Clin Epidemiol. 1990;43:285–295
  33. Barlow WE, Ichikawa L, Rosner D, et al. Analysis of case-cohort designs. J Clin Epidemiol. 1999;52:1165–1172
  34. Casparie M, Tiebosch AT, Burger G, et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol. 2007;29:19–24
  35. van den Brandt PA, Schouten LJ, Goldbohm RA, et al. Development of a record linkage protocol for use in the Dutch Cancer Registry for Epidemiological Research. Int J Epidemiol. 1990;19:553–558
  36. Goldbohm R, van Den Brandt PA, Dorant E. Estimation of the coverage of Dutch municipalities by cancer registries and PALGA based on hospital discharge data. Tijdschr Soc Gezondheidsz. 1994;72:80–84
  37. Parkin DM, Shanmugaratnam K, Sobin L. Histological Groups for comparative studies. In: IARC Technical reports. 31:Lyon: International Agency for Research on Cancer; 1998;
  38. Nevo table: Dutch food composition table, 1986–1987. Voorlichtingbureau Voor de Voeding, 1986.
  39. Zeegers MP, Goldbohm RA, Bode P, et al. Prediagnostic toenail selenium and risk of bladder cancer. Cancer Epidemiol Biomarkers Prev. 2002;11:1292–1297
  40. Bode P. Automation and quality assurance in the neutron activation facilities in Delft. J Radioanal Nucl Chem. 2000;245:127–132
  41. van den Brandt PA, Goldbohm RA, van ‘t Veer P, et al. Predictors of toenail selenium levels in men and women. Cancer Epidemiol Biomarkers Prev. 1993;2:107–112
  42. van Breda SG, Hogervorst JG, Schouten LJ, et al. Toenails: an easily accessible and long-term stable source of DNA for genetic analyses in large-scale epidemiological studies. Clin Chem. 2007;53:1168–1170
  43. Goldbohm RA, van den Brandt PA, Brants HA, et al. Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur J Clin Nutr. 1994;48:253–265
  44. Schottenfeld D, Fraumeni JF. Cancer epidemiology and prevention. New York: Oxford University Press; 2006;
  45. Merry AH, Schouten LJ, Goldbohm RA, et al. Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study. Gut. 2007;56:1503–1511
  46. Lagergren J, Bergstrom R, Adami HO, et al. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med. 2000;133:165–175
  47. WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcddd/welcome.htmlAccessed October 15, 2009
  48. Cox DR. Regression models and life-tables. (with discussion) J Roy Statistical Society. 1972;34:187–220
  49. Barlow WE. Robust variance estimation for the case-cohort design. Biometrics. 1994;50:1064–1072
  50. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrica. 1982;69:239–241
  51. Gao S, Jin Y, Hall KS, et al. Selenium level and cognitive function in rural elderly Chinese. Am J Epidemiol. 2007;165:955–965
  52. Ovaskainen ML, Virtamo J, Alfthan G, et al. Toenail selenium as an indicator of selenium intake among middle-aged men in an area with low soil selenium. Am J Clin Nutr. 1993;57:662–665
  53. Garland M, Morris JS, Rosner BA, et al. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev. 1993;2:493–497
  54. Koriyama C, Campos FI, Yamamoto M, et al. Toenail selenium levels and gastric cancer risk in Cali, Colombia. J Toxicol Sci. 2008;33:227–235
  55. Zhang ZW, Shimbo S, Qu JB, et al. Dietary selenium intake of Chinese adult women in the 1990s. Biol Trace Elem Res. 2001;80:125–138
  56. Kabuto M, Imai H, Yonezawa C, et al. Prediagnostic serum selenium and zinc levels and subsequent risk of lung and stomach cancer in Japan. Cancer Epidemiol Biomarkers Prev. 1994;3:465–469
  57. Nomura A, Heilbrun LK, Morris JS, et al. Serum selenium and the risk of cancer, by specific sites: case-control analysis of prospective data. J Natl Cancer Inst. 1987;79:103–108
  58. Li JY, Taylor PR, Li B, et al. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst. 1993;85:1492–1498
  59. Xiao HJ, Huang CY, Wang HY, et al. Effect of selenium and zinc on the proliferation of human esophageal cancer Eca109 cell line in vitro. Nan Fang Yi Ke Da Xue Xue Bao. 2008;28:2117–2120
  60. Guttenplan JB, Kosinska W, von Pressentin MM, et al. Effects of 1,4-phenylenebis(methylene)selenocyanate (p-XSC) and vitamin E on 4-nitroquinoline-N-oxide (4-NQO)-induced mutagenesis in lacZ mouse upper aerodigestive tissue. Mutat Res. 2002;518:85–93
  61. Guttenplan JB, Spratt TE, Khmelnitsky M, et al. Effects of 3H-1,2-dithiole-3-thione, 1,4-phenylenebis(methylene)selenocyanate, and selenium-enriched yeast individually and in combination on benzo[a]pyrene-induced mutagenesis in oral tissue and esophagus in lacZ mice. Mutat Res. 2004;559:199–210
  62. Bogden JD, Chung HR, Kemp FW, et al. Effect of selenium and molybdenum on methylbenzylnitrosamine-induced esophageal lesions and tissue trace metals in the rat. J Nutr. 1986;116:2432–2442

 Conflicts of interest The authors disclose no conflicts.

 Funding Supported by grant UM 2006-3562 from the Dutch Cancer Society. The Dutch Cancer Society had no involvement in study design, in collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the report for publication.

PII: S0016-5085(09)02112-X

doi: 10.1053/j.gastro.2009.12.004

Gastroenterology
Volume 138, Issue 5 , Pages 1704-1713 , May 2010

Article Tools